Exploring the Inhibition of Toxoplasma gondii α-Carbonic Anhydrase by Sulfonamides: Insights into Potential Drug Targeting
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms26010116 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Simone Giovannuzzi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Neurofarba Department, Section of Pharmaceutical Sciences, University of Florence, Via Ugo Schiff 6, Sesto Fiorentino, 50019 Florence, Italy. Hauptthemen laut MEDLINE: Toxoplasma, Carbonic Anhydrase Inhibitors, Sulfonamides, Carbonic Anhydrases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Toxoplasma gondii, the causative agent of toxoplasmosis, is a protozoan parasite capable of infecting a wide range of hosts, posing significant health risks, particularly to immunocompromised individuals and congenital transmission. Current therapeutic options primarily target the active tachyzoite stage but are limited by issues such as toxicity and incomplete efficacy. As a result, there is an urgent need for alternative therapies that can selectively target parasite-specific mechanisms critical for metabolic processes and host–parasite interactions. In this context, α-carbonic anhydrase (Tg_CA), an enzyme essential for T. gondii survival has emerged as a promising drug target. Tg_CA was successfully expressed and purified to evaluate its susceptibility to sulfonamide-based inhibitors, represented by compounds 1–24 and the AAZ–HCT series. These inhibitors demonstrated a broad spectrum of activity, with KI values ranging from 17.8 to 8450 nM. Several compounds exhibited moderate to high potency against Tg_CA; however, concerns regarding selectivity arose because of the inhibition of human isoforms, particularly CA I and CA II. Thus, although some inhibitors showed strong activity against Tg_CA, optimizing selectivity remains crucial for minimizing off-target effects and improving therapeutic efficacy. Further structural modifications may enhance selectivity and advance the development of effective treatments for toxoplasmosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurofarba Department, Section of Pharmaceutical Sciences, University of Florence, Via Ugo Schiff 6, Sesto Fiorentino, 50019 Florence, Italy.
- Department of Biology, Agriculture and Food Sciences, National Research Council (CNR), Institute of Biosciences and Bioresources, 80131 Naples, Italy.
ORCID-Profile: Simone Giovannuzzi, Viviana De Luca, Clemente Capasso, Claudiu T Supuran
Zitieren
APA
Giovannuzzi, S., De Luca, V., Capasso, C., & Supuran, C. T. (2024). Exploring the Inhibition of Toxoplasma gondii α-Carbonic Anhydrase by Sulfonamides: Insights into Potential Drug Targeting. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26010116
Vancouver
Giovannuzzi S, De Luca V, Capasso C, Supuran CT. Exploring the Inhibition of Toxoplasma gondii α-Carbonic Anhydrase by Sulfonamides: Insights into Potential Drug Targeting. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms26010116
BibTeX
@article{Giovannuzzi2024,
author = {Giovannuzzi, Simone and De Luca, Viviana and Capasso, Clemente and Supuran, Claudiu T},
title = {Exploring the Inhibition of Toxoplasma gondii α-Carbonic Anhydrase by Sulfonamides: Insights into Potential Drug Targeting},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms26010116}
}
EUVIMED